Patti Lehigh Ph.D., RAC

Inspirer
DISC Type : id

Director Clinical Research Regulatory Affairs at St. Jude Children's Research Hospital

Shelby County, Tennessee, United States

Overview

Patti Lehigh is the Director of Clinical Research Regulatory Affairs at St. Jude Childrens Research Hospital. An expert with a Ph. D. from Louisiana State University and RAC certification, she has deep experience in regulatory submissions for drugs and medical devices. Colleagues describe her as knowledgeable, efficient, and accurate.

Based in Memphis, Patti demonstrates a strong passion for social justice and allyship. She actively follows developments in the broader pharmaceutical industry, taking an interest in major companies like GSK and Abbott, reflecting her commitment to staying current on industry trends.

She has a unique background spanning corporate medical device development at Bayer and pediatric clinical research at St. Jude.

Personality Overview

Confident & Optimistic

Decisive

Generous

They usually prefer to drive the conversation.  They measure a product on its merit but can be influenced by strong testimonials. They respond well to objective pitches but also attach some value to relationships.

Topics They Care About

Regulatory Strategy
As a certified director, she has an extensive background in managing agency submissions for investigational products, new drugs, and medical devices.
Pediatric Clinical Research
Her current role is centered on managing the complex regulatory affairs for clinical research specifically involving children at a leading research hospital.
Medical Device Regulation
Her prior experience at Bayer HealthCare included roles focused on medical device R&D, design control, and risk management.

Media Appearances

Patti has no verified media appearances

Work History

5-2019
Director Clinical Research Regulatory Affairs at St. Jude Children's Research Hospital
8-2018 - 2-2019
Quality and Regulatory Specialist at MAETRICS
8-2018 - 2-2019
Senior Associate Quality, Clinical Research and Regulatory Affairs Specialist at MAETRICS
3-2015 - 5-2018
Senior Associate Director CAPA Risk Manager at Bayer HealthCare
9-2012 - 2-2015
Associate Principal Scientist - Medical Devices at Bayer HealthCare

Education

1989 - 1995
Ph.D. from Louisiana State University
Doctor of Philosophy - PhD from Louisiana State University

More Information

Social Presence :

Prographics :

Exp : 30 Location : Shelby County, Tennessee, United States Job Level : Mid-senior Designation : Director Clinical Research Regulatory Affairs at St. Jude Children's Research Hospital
URL has been copied!

Insights For Selling To Patti

During A Call Or A Meeting

DO's

  • Acknowledge their status and position during the conversation
  • Focus on the big picture and the strategic value of your product
  • Look like someone who is on top of their game

DONT's

  • Don’t be too verbose or overly friendly; a little bit, however, is fine
  • Avoid focusing only on the product or its ROI, keep building trust subtly
  • Don’t keep repeating the same information, it could make them impatient

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Patti is

  • Belief in the value of the product, relationship and a sense of accomplishment matter the most.
  • Will you ever get a clear answer from Patti

  • They are not shy of saying no if they do not develop trust in your product.

Insights For Deal Planning

    How fast (or slow) will Patti move?

  • They can take fast decisions if they develop conviction in the product and find you trustworthy.
  • Can Patti take some risk or not?

  • They have the capability of taking risky decisions if necessary.

You And Patti

Personality Compatibility


Other St. Jude Children's Research Hospital Employees

Explore more public profiles from related professionals at the same organization.

More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.